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1. Introduction 
Methoxy-9-ellipticine (MEL) is an alkaloid extracted 
from barks of Ochrosia maculata (= 0. Borbonica) [ I] . 
Its formula which is characterized by indol and iso- 
quinoleine moietiesis shown in fig. 1. The main feature 
of this tetracyclic drug is its structural resemblance 
with the well known DNA intercalating drugs, acridines 
and phenanthridines; they all share a flat structure and 
a similar size. Therefore, one could expect that MEL 
would also be able to form an intercalation complex 
with double stranded DNA resulting in a local distortion 
of the DNA molecules and their lengthening [2]. 
These modifications which involve changes of the 
hydrodynamic properties of the polymer have been 
observed by viscometry either on linear [3-S] or on 
covalently closed circular molecules [6]. 
Fig. 1. Methoxy8ellipticine (chlorhydrate: 
PM = 312.5-log X(hf)309rm = 4.58). 
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2. Material and methods’ 
Calf thymus DNA [7] was sonicated in a cacodylate 
buffer p = 0.01 pH 6.5 (concentration 1 mglml) 
saturated with nitrogen at 4’ in a Branson sonifier; 
repeated ultrasonication cycles were performed 30 
set, each for 10 min. 
‘Ihe final product was made of rods 3.5 X 10’ 
daltons; its T, and hyperchromicity were identical to 
those of non sonicated DNA. Its intrinsic viscosity was 
1.8 dl/g. 
The bacteriophage PM2 and its host bacteria, 
Pseudomonas BAL 3 1, were kindly given to us by 
Dr. R.T. Espejo [8] ; the PM2 DNA was prepared as 
closed circles as described by Paoletti and Le Pecq 
[9] . The final dialysis was performed for both linear 
and circular DNA against a cacodylate buffer p = 0.05 
pH 6.5. 
Control drugs, ethidium bromide (EB) and hydroxy- 
stilbamidine (OHSA) were purchased from Boots 
pure Drugs Co. Nottingham (GB) and May-Baker 
Dagenham (GB). 
MEL was prepared according to a method previously 
described [ 11. 
Viscometric measurements were carried out in an 
Oswald capillary viscometer at 20’ and 25” (kO.02’) 
in the cacodylate buffer; shear gradient was 500 set-’ .
Flow times for the equilibrium solutions were about 
50-55 set while the DNA solutions had 5-100 set 
longer flow times; the long afflux times made kinetic 
energy corrections negligible. The reduced viscosity 
(Q& of sonicated DNA does not depend on its con- 
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centration [4] in the 150-750 pg/rnl concentration 
range. nred was determined at one DNA concentration 
for each D/P ([dye] / [nucleotide] ) value. 
Relative increase in length of rodlike DNA mole- 
cules. L/L,, , were obtained through the relationship 
U, =(M7?olP3.[41. 
For circular DNA, such as PM2 DNA, the magnitude 
of qred is lowered by the effects of shear gradients [6] 
which however have no influence on the position of 
the equivalence point (D/P for which maximum relaxa- 
tion is observed) or the shape of the titration curve; in 
this case also, nti is nearly independent of the concen- 
tration of DNA. 
After addition of a concentrated solution of dye 
(10M3 M), the solutions were mixed with a small flow 
of air through the dilution bulb of the viscometer. In 
our concentration conditions, the dye was almost 
totally bound on DNA [ 10,111. 
3. Results 
A comparative set of data were obtained with MEL, 
EB and OHSA: EB is well known as a model for inter- 
cdating drugs [IO, 121 while OHSA is unable to be- 
come intercalated although it can modify the polymer 
structure by an internal binding to it [ 1 I] . 
On sonicated linear DNA, MEL elicited at both 
/.I = 0.05 and /J = 1 .O ionic strength, an important in- 
crease of viscosity which was related to the increase 
of the hydrodynamic volume of DNA (fig. lb). 
This increase was of the same order of magnitude 
1 P&‘/9l a 
E8 
DHSA 
Fig. 2. Viscometry of DNA after addition of methoxy-9ellipticine (MEL). Cacodylate pH 6.5 cc = 0.05 unless otherwise stated; T : 
20” (EB-OHSA) 25” (MEL). (a) Circular closed PM2 DNA: DNA initial concentrations @g/ml): EB = 850 (A); OHSA = 560 (0); 
MEL.? 107 (X). (b) Sonicated calf thymus DNA: DNA initial concentration (rg/ml): 495; ionic strength (MEL) ti = 0.05 (X) and 
p = 1 (c). 
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as the one due to EB at 20” and it verified one of the 
predictions of the intercalation model according to 
which the relationship between L/L, and r must be 
L/L, = ! t 2r [2], I being the number of dye mole- 
cules bound per nucleotide. 
On the closed circular DNA, the addition of MEL 
elicited drastic changes of nred which, after a slight 
modification at the lowest concentrations of the dye, 
is very much increased for the higher concentrations 
up to a maximum which is the transition point; finally, 
vred decreased abruptly (fig. la). The interpretation 
of the phenomenon has already been presented by 
Revet et al. [6] : the amount of intercalated dye per 
nucleotide at the transition point is the one just 
necessary for obtaining a complete relaxation of the 
DNA circles. 
Qualitatively, EB titration yielded the same sequence 
of events and allowed the determination of the super- 
helix density u,, of PM2 DNA; in our conditions, u,, 
was about 0.032 if one accepts the value of 12’ for the 
unwinding angle of DNA base pairs for each intercal- 
ated EB molecule [ 131 . This value if open to discus- 
sion [14]. 
In contrast, OHSA induced only slight variations of 
viscosity in both systems as expected from its mechan- 
ism of binding on DNA. 
4. Discussion 
These experiments give an unequivocal answer: MEL 
does intercalate between the base pairs of DNA at low 
and high ionic strengths. 
‘The changes of twisting of closed circular DNA is 
very indicative of an intercalation process but not 
totally specific for it, as established when the steroidal 
diamine, irehdiamine [ 12, 151 was studied; thereforee 
this test must be ascertained by a direct demonstration 
of the changes of the morphology of DNA which is pro- 
vided by the hydrodynamic measurement on rodlike 
molecules. 
Up to date, all intercalating drugs display active 
pharmacological properties (mostly antitumoral and 
parasicidal). Once more, MEL obeys this general rule 
since this intercalating alkaloid has been demonstrated 
to induce remissions of myeloblastic acute leukemia in 
[ 141 J. Paoletti and J.B. Le Pecq, J. Mol. BioL 59 (197 1) 
in press. 
115 ] J.M. Saucier, to be published. 
[16 ‘1 G. Mathe, M. Hayat, F. De Vassal, L. Schwarzenberg, 
M. Schneider, J.R. Schlumberger, C. Jasmin and C. 
Rosenfeld, Rev. Europ. Etudes Clin. Biol. 15 
(1970) 541. 
117 ] J. Le Men, M. Hayat, G. Mathe, J.C. Guillon, E. 
Chenu, M. Humblot and Y. Masson, Rev. Europ. Etudes 
Clin. Biol. 15 (1970) 534. 
[ 181 G. Riou, personal communication. 
[ 191 E. Garcia-Giralt and A. MacieiraCoelho, Rev. Europ. 
Etudes Clin. BioL 15 (1970) 539. 
man [ 161 ; it displays antitumoral and immunosuppressive 
activity [ 171 in mice; morever, it exhibits a very active 
[20] A.L. Snyder, H.E. Kann and K.W. Kohn, J. MoL Biol. 
58 (1971) 555. 
trypanocidal action in vitro (fgpznosoma cruzi) [ 181. 
It inhibits DNA, RNA, and protein synthesis [ 191 
in fibroblasts and interferes with the process of matura- 
tion of the nucleolar 45 S RNA &B &osomal RNAs in 
L 1210 mouse lymphoma cells [2Dj. 
A complete physic0 chemical stu&y on the MEL- 
DNA interaction has been undertaken. 
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